Table 1 Comparison between serum levels of nucleosomes, CEA and CA 19-9 in the three patient groups versus the control group and each group of patients versus the other groups
Parameters Groups | Nucleosomes (AU) | CEA (ng/ml) | CA 19-9 U/ml | ||
|---|---|---|---|---|---|
Control group (n = 6) | Median | 282.6 | 2.3 | 20.9 | |
S.E ± | 26.4 | 0.39 | 3.2 | ||
Range | Min. | 181.5 | 0.8 | 7.8 | |
Max. | 519.2 | 4.2 | 41.4 | ||
Group I Patients (well differentiated tumor) (n = 9) | Median | 1081 | 6.6 | 32.86 | |
S.E ± | 209.5 | 9.00 | 101.6 | ||
Range | Min. | 712.4 | 1.29 | 8.4 | |
Max. | 3382.5 | 1729 | 1895 | ||
Group II Patients | Median | 1776.2 | 4.61 | 23.9 | |
(moderate differentiated tumor) (n = 9) | S.E ± | 171.3 | 75.6 | 64.6 | |
Range | Min. | 772.2 | 1.6 | 1.6 | |
Max. | 3426.9 | 2400 | 2246 | ||
Group III | Median | 1860 | 4.6 | 34 | |
Patients (poor differentiated tumor) (n = 6) | S.E ± | 260.6 | 6.26 | 44.66 | |
Range | Min. | 1149.7 | 1.72 | 3.16 | |
Max. | 3482.5 | 52.6 | 386.2 | ||
P control versus group I | <0.001 | <0.001 | 0961 | ||
P control versus group II | <0.001 | 0.037 | 0.666 | ||
P control versus group III | <0.001 | 0.106 | 0.816 | ||
P group I versus group II | 0.086 | 0.464 | 0.116 | ||
P group I versus group III | 0.041 | 0.569 | 0.450 | ||
P group II versus group III | 0.566 | 0.861 | 0.627 | ||